Weighted Average Number of Shares Outstanding, Diluted of Biostax Corp. from 30 Jun 2016 to 30 Jun 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Biostax Corp. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 30 Jun 2016 to 30 Jun 2024.
  • Biostax Corp. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Jun 2024 was 83,698,396, a 0.5% increase year-over-year.
  • Biostax Corp. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 83,510,001, a 130% increase from 2022.
  • Biostax Corp. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 36,290,359, a 286% increase from 2021.
  • Biostax Corp. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 9,394,164, a 41% decline from 2020.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

Biostax Corp. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2024 83,698,396 +413,342 +0.5% 01 Apr 2024 30 Jun 2024 10-Q 19 Aug 2024 2024 Q2
Q1 2024 83,711,316 +468,237 +0.56% 01 Jan 2024 31 Mar 2024 10-Q/A 19 Aug 2024 2024 Q1
Q4 2023 83,510,001 +47,219,642 +130% 01 Oct 2023 31 Dec 2023 10-K/A 05 Jul 2024 2023 FY
Q3 2023 83,239,115 +23,149,810 +39% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 83,285,054 +75,480,506 +967% 01 Apr 2023 30 Jun 2023 10-Q 19 Aug 2024 2024 Q2
Q1 2023 83,243,079 +82,759,365 +17109% 01 Jan 2023 31 Mar 2023 10-Q/A 19 Aug 2024 2024 Q1
Q4 2022 36,290,359 +26,896,195 +286% 01 Oct 2022 31 Dec 2022 10-K/A 05 Jul 2024 2023 FY
Q3 2022 60,089,305 +47,098,373 +363% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
Q2 2022 7,804,548 +7,322,642 +1520% 01 Apr 2022 30 Jun 2022 10-Q 18 Aug 2023 2023 Q2
Q1 2022 483,714 -16,111,181 -97% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023 2023 Q1
Q4 2021 9,394,164 01 Oct 2021 31 Dec 2021 10-K 10 Apr 2023 2022 FY
Q3 2021 12,990,932 +12,533,354 +2739% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 481,906 01 Apr 2021 30 Jun 2021 10-Q 24 Aug 2022 2022 Q2
Q1 2021 16,594,895 +16,137,317 +3527% 01 Jan 2021 31 Mar 2021 10-Q 03 May 2022 2022 Q1
Q3 2020 457,578 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021 2021 Q3
Q1 2020 457,578 01 Jan 2020 31 Mar 2020 10-Q 24 May 2021 2021 Q1
Q2 2018 395,149,691 +81,571,410 +26% 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2018 2018 Q2
Q2 2017 313,578,281 +106,348,812 +51% 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018 2018 Q2
Q2 2016 207,229,469 01 Apr 2016 30 Jun 2016 10-Q 14 Aug 2017 2017 Q2

Biostax Corp. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 83,510,001 +47,219,642 +130% 01 Jan 2023 31 Dec 2023 10-K/A 05 Jul 2024 2023 FY
2022 36,290,359 +26,896,195 +286% 01 Jan 2022 31 Dec 2022 10-K/A 05 Jul 2024 2023 FY
2021 9,394,164 -6,553,309 -41% 01 Jan 2021 31 Dec 2021 10-K 10 Apr 2023 2022 FY
2020 15,947,473 01 Jan 2020 31 Dec 2020 10-K 15 Apr 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.